|
HY-100034-10mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-100mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-2mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-25mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-5mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-50mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100233-10mg
|
MedChemexpress LLC
|
IQ-1S (free acid) [CAS 23146-22-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100233-100mg
|
MedChemexpress LLC
|
IQ-1S (free acid) [CAS 23146-22-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100233-25mg
|
MedChemexpress LLC
|
IQ-1S (free acid) [CAS 23146-22-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100233-5mg
|
MedChemexpress LLC
|
IQ-1S (free acid) [CAS 23146-22-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100233-50mg
|
MedChemexpress LLC
|
IQ-1S (free acid) [CAS 23146-22-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100462-10mg
|
MedChemexpress LLC
|
PTP1B-IN-2 [CAS 1919853-46-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100462-100mg
|
MedChemexpress LLC
|
PTP1B-IN-2 [CAS 1919853-46-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100462-25mg
|
MedChemexpress LLC
|
PTP1B-IN-2 [CAS 1919853-46-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100462-5mg
|
MedChemexpress LLC
|
PTP1B-IN-2 [CAS 1919853-46-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100462-50mg
|
MedChemexpress LLC
|
PTP1B-IN-2 [CAS 1919853-46-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100463-10mg
|
MedChemexpress LLC
|
TPI-1 [CAS 79756-69-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-100463-100mg
|
MedChemexpress LLC
|
TPI-1 [CAS 79756-69-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-100463-5mg
|
MedChemexpress LLC
|
TPI-1 [CAS 79756-69-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-100463-50mg
|
MedChemexpress LLC
|
TPI-1 [CAS 79756-69-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-100595-1g
|
MedChemexpress LLC
|
Sodium stibogluconate [CAS 16037-91-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-100595-500mg
|
MedChemexpress LLC
|
Sodium stibogluconate [CAS 16037-91-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-100625-10mg
|
MedChemexpress LLC
|
BVT948 [CAS 39674-97-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-100625-100mg
|
MedChemexpress LLC
|
BVT948 [CAS 39674-97-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-100625-5mg
|
MedChemexpress LLC
|
BVT948 [CAS 39674-97-0]
|
|
Cancer-Kinase/protease
|
|
